March 31 (Reuters) – Novo Nordisk has again cut the prices of its blockbuster diabetes and weight-loss drugs Ozempic and Wegovy by up to 36% and 48% in India, to fend off competition from cheaper ...
* you may not use this file except in compliance with the License. * You may obtain a copy of the License at * https://www.apache.org/licenses/LICENSE-2.0 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results